Markforged 85 School St.Watertown, MA 02472617-666-1935https://markforged.com/ Key contact Name Title Greg Mark CEO WATERTOWN, MA, Leading manufacturer of industrial 3D printers, today announced that it has closed an $82 million Series D round of funding. Markforged, a leading manufacturer of industrial 3D printers, today announced that it has closed an $82 million Series D round […]
Archivio Categoria: venture capital funding
19
Mar
Mar
Mojo Vision Saratoga, CA 95070https://mojo.vision/ Key contact Name Title Drew Perkins CEO SARATOGA, CA, Mojo Vision today announced it has raised $58 million in a Series B investment round designed to propel development of its new augmented reality platform. The new round brings Mojo Vision's total funding to date to over $108 million. Mojo Vision's […]
19
Mar
Mar
Marketing Evolution 122 E. 42nd St, Suite 4400New York, NY 10168646-651-4300https://www.marketingevolution.com/ Key contact Name Title Rex Briggs Founder & CEO NEW YORK, NY, Marketing Evolution, provider of powerful marketing measurement and optimization solutions, today announced $26.1 million in growth financing. The round was led by Energy Impact Partners (EIP), a leading utility-backed energy investment and […]
19
Mar
Mar
EaseCentral 1086 Howard StreetSan Francisco, CA 94103800-446-EASEhttps://www.easecentral.com/ Key contact Name Title David Reid CEO SAN FRANCISCO, CA, Ease, a leading HR and benefits software solution for SMBs, insurance brokers, and insurance carriers, today announced the close of its $19 million Series B funding round. The round was led by Centana Growth Partners with continued participation […]
18
Mar
Mar
Shotzr 1127 Auraria Parkway, Suite 201Denver, CO 80204303-481-1757https://www.shotzr.com/ Key contact Name Title Frank Cardello Co-Founder DENVER, CO, Shotzr announced that it has closed a $3M Series Seed equity financing round led by Access Venture Partners. Shotzr, Inc., announced that it has closed a $3M Series Seed equity financing round. Access Venture Partners led the round […]
AmplifAI 101 W Renner Rd. #180Richardson, TX 75082https://www.amplifai.com/ Key contact Name Title Sean Minter CEO RICHARDSON, TX, Performance Acceleration Platform for enterprise contact centers, announces a $3.9 million round of funding. AmplifAI Solutions, Inc., the #1 Performance Acceleration Platform for enterprise contact centers, announces a $3.9 million round of funding with Naya Ventures, LiveOak Venture […]
18
Mar
Mar
LeanData 111 West Evelyn Ave. Suite 106Sunnyvale, CA 94086408-827-5326http://www.leandatainc.com/ Key contact Name Title Evan Liang CEO SUNNYVALE, CA, Leader in enterprise Revenue Ops, today announced it has secured $27.5 million in financing led by new investor Tenaya Capital. LeanData, the leader in enterprise Revenue Ops, today announced it has secured $27.5 million in financing led […]
18
Mar
Mar
Karuna Pharmaceuticals 33 Arch Street, Suite 3110Boston, MA 02110617-482-2333http://karunatx.com/ Key contact Name Title Andrew Miller CEO BOSTON, MA, Karuna Therapeutics announced the completion of a $68 million Series B financing round. Karuna Therapeutics, Inc. ("Karuna," formerly Karuna Pharmaceuticals), focused on targeting muscarinic cholinergic receptors for the treatment of neuropsychiatric disorders including psychosis in schizophrenia, psychosis […]
18
Mar
Mar
Cold Genesys 6 Hutton Centre Drive, Suite #1220Santa Ana, CA 92702714-884-3953http://coldgenesys.com/ Key contact Name Title Alex Yeung CEO SANTA ANA, CA, Clinical-stage biopharmaceutical company focused on the development of novel immunotherapies, today announced the closing of a $22 million Series C. Cold Genesys, Inc., a clinical-stage biopharmaceutical company focused on the development of novel immunotherapies, […]
18
Mar
Mar
Imara 700 Technology Square, 3rd FloorCambridge, MA 02139617-231-6021http://www.imaratx.com/ Key contact Name Title Rahul D. Ballal CEO CAMBRIDGE, MA, Clinical-stage biopharmaceutical company focused on sickle cell disease and other hemoglobinopathies, has closed an oversubscribed $63M Series B. Imara Inc., a clinical-stage biopharmaceutical company focused on sickle cell disease (SCD) and other hemoglobinopathies, today announced the closing […]